Trump's travel ban stalls lifesaving treatment for Haitian children who need to travel for surgery
Leaders of an aid organization that has sent more than 100 Haitian children with serious cardiac conditions to the U.S. for heart surgery said President Donald Trump's ban on travelers from 19 countries will stall or cancel lifesaving procedures for at least a dozen children or young adults.
The ban, which goes into effect Monday, has led to widespread uncertainty for many and drawn condemnation from international leaders. The proclamation issued Tuesday offered exceptions for those who are lawful permanent U.S. residents and those traveling to the U.S. for the World Cup and the Olympics, among other examples. No such mention was made for cases of medical necessity, such as those who are seeking treatment in the U.S. through the International Cardiac Alliance.
The International Cardiac Alliance's total waitlist for Haitians, ranging from infants to young adults, totals at least 316 people who need heart surgery, said Executive Director Owen Robinson. Some are placed in hospitals in the Dominican Republic and occasionally the Cayman Islands. But there are currently five open surgical slots in the U.S.
'Some of them might be able to wait a few months, and others, if they don't go now, they're going to pass away very quickly,' Robinson said.
The president's executive order adds that the secretary of state can issue exemptions for visas in cases that 'serve a United States national interest.' It is unclear if clients of the International Cardiac Alliance with medical needs would fit into that description. Neither the White House nor the State Department responded to a request for comment on the matter.
'We do have kids die every week waiting because there's not a lot of international slots for these kids,' Robinson said.
Some of the children in the program travel directly from their home country to the U.S., undergo surgery, and then return to Haiti. But for many Haitians, international travel requires multiple levels of logistical wrangling, Robinson said. Some patients and their parents who can secure surgeries in other countries must apply for a visa to the U.S., travel here, and then head to their eventual destination. The United States' travel ban now throws a wrench in that process.
Fabienne Rene, 16, was diagnosed with rheumatic heart disease in February. Because of her condition, Fabienne, who lives in Port-au-Prince, cannot even attend school since she experiences shortness of breath, said her father, Fignole Rene. The 'bad news' he received about the travel ban causing the postponement or potential cancellation of his daughter's travel through the U.S. to the Dominican Republic is 'really disturbing and breaking my heart,' he said.
'I was not waiting to hear something like that,' Rene, 53, said in Creole through a translator. 'We know for sure that there is nowhere in Haiti we can have this possibility. The only option that we have was just waiting to have an open door from the Cardiac Alliance.'
He also said the news will be troubling for his family to hear and that they don't know 'where they will find another open door that can give her a chance.'
Robinson said the U.S. Embassy in Haiti recently informed him that it most likely wouldn't be able to issue any visas due to the travel ban. In the past, the embassy has repeatedly issued visas for Haitian children to travel to the U.S. for care. The office of Rep. Becca Balint, D-Vt., has offered to reach out to the State Department to see if the children can receive exceptions, he added.
Dr. John Clark, a pediatric cardiologist at Akron Children's Hospital in Ohio who has worked with the ICA, said many children in impoverished countries like Haiti suffer from Fabienne's condition because they are not seen by a doctor and treated for the common illness strep throat. Untreated, recurring strep infections can lead to rheumatic heart disease.
St. Damien Pediatric Hospital in Port-au-Prince received visiting pediatric surgical teams from 2015 to 2019, Robinson said. Now, dangerous conditions in Haiti prevent doctors from other countries from entering or providing care. Meanwhile, Haiti does not have enough doctors practicing there, and the loss of opportunities for a medical education in Haiti only perpetuates the problem, Clark said.
Clark participated in a surgical mission there in 2019, when visiting U.S. doctors were performing two heart surgeries per day, he said. A drastic rise in gang violence — including an attack on one of the hospital's ambulances and a worker being stoned to death — ended most medical missions to Haiti.
Gang violence has only escalated since then, United Nations figures show, particularly after the assassination of Haiti's President Jovenel Moïse in 2021. Haiti is one of the poorest countries in the world, and more than half of Haitians live below the poverty line. The country is also plagued with government corruption, gang violence and food insecurity, as well as vulnerability to natural disasters, including a devastating 2010 earthquake that killed at least 220,000 people. Lack of adequate health care also fuels diseases like cholera, according to the Council on Foreign Relations.
'I hope things can calm down one day enough that we can get back there [to Haiti],' Clark said. 'But right now, there's no way for us to go back down.'
Andrice Boncoeur of Port-au-Prince received free open-heart surgery at CEDIMAT Cardiovascular Center in the Dominican Republic to repair a valve when he was 9 years old. That procedure, however, was only meant to be a temporary solution. Now, plans for Andrice, 16, to travel through the U.S. for more permanent surgery have been disrupted.
On Thursday, Andrice's father, Andre Boncoeur, said he had not yet told his son about the travel ban preventing him from passing through the U.S. Boncoeur said he knows 'something can change at any time.'
Still, children like Andrice do not have much time to wait. In April, Andrice was once again hospitalized for three days at Haiti's Centre Hospitalier Eben-Ezer for heart failure. Boncoeur said his family has spent 'everything that we had' and that their funds are 'almost gone.' He said he hopes the situation will change so that his son, who aspires to become a pastor, 'can have a chance to live his life as a normal kid.'
Clark, Robinson and the patient's parents all agree it comes down to the Trump administration's willingness to accommodate the sick children.
'These children are somebody's child and somebody's grandchild and they don't have access to lifesaving care,' Clark said. 'Is there any room for compassion?'
This article was originally published on NBCNews.com
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Newsweek
4 hours ago
- Newsweek
How Animal Testing in US Could Be Transformed Under Trump
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. Millions of animals each year are killed in U.S. laboratories as part of medical training and chemical, food, drug and cosmetic testing, according to the non-profit animal rights organization People for the Ethical Treatment of Animals (PETA). For many animals held captive for research, including a huge range of species from dogs, cats and hamsters to elephants, dolphins and many other species, pain is "not minimized," U.S. Department of Agriculture data shows. The issue of animal testing is something most Americans agree on: it needs to change and gradually be stopped. A Morning Consult poll conducted at the end of last year found that 80 percent of the 2,205 participants either agreed or strongly agreed with the statement: "The US government should commit to a plan to phase out experiments on animals." Since President Donald Trump began his second term, his administration has been making moves to transform and reduce animal testing in country, although the question remains as to whether it will be enough to spare many more animals from pain and suffering this year. Animal Testing In US Could Be Transformed Animal Testing In US Could Be Transformed Photo-illustration by Newsweek/Getty/Canva What Is The Trump Administration Doing About It? There have been various steps taken in different federal agencies to tackle the issue of animal testing since Trump was sworn in on January 20. In April, the Food and Drug Administration (FDA) announced it was "taking a groundbreaking step to advance public health by replacing animal testing in the development of monoclonal antibody therapies and other drugs with more effective, human-relevant methods." The FDA said that its animal testing requirement will be "reduced, refined, or potentially replaced" with a range of approaches, including artificial intelligence-based models, known as New Approach Methodologies or NAMs data. A Department of Health and Human Services (HHS) official told Newsweek: "The agency is paving the way for faster, safer, and more cost-effective treatments for American patients. "As we restore the agency's commitment to gold-standard science and integrity, this shift will help accelerate cures, lower drug prices, and reaffirm U.S. leadership in ethical, modern science." The National Institutes of Health (NIH) announced it was "adopting a new initiative to expand innovative, human-based science while reducing animal use in research," in alignment with the FDA's initiative. The agency said that while "traditional animal models continue to be vital to advancing scientific knowledge," new and emerging technologies could act as alternative methods, either alone or in combination with animal models. The NIH Office of Extramural Research told Newsweek it was "committed to transparently assessing where animal use can be reduced or eliminated by transitioning to [new approach methodologies (NAMs)]." "Areas where research using animals is currently necessary represent high-priority opportunities for investment in NAMs," the agency added. It added that it will "further its efforts to coordinate agency-wide efforts to develop, validate, and scale the use of NAMs across the agency's biomedical research portfolio and facilitate interagency coordination and regulatory translation for public health protection." During Trump's first term, the Environmental Protection Agency (EPA) signed a directive to "prioritize efforts to reduce animal testing and committed to reducing testing on mammals by 30 percent by 2025 and to eliminate it completely by 2035," an EPA spokesperson told Newsweek. Although, the spokesperson added: "the Biden Administration halted progress on these efforts by delaying compliance deadlines." As a member of the House, Lee Zeldin, the EPA's current administrator, co-sponsored various bills during Trump's first term regarding animal cruelty, covering issues such as phasing out animal-based testing for cosmetic products; ending taxpayer funding for painful experiments on dogs at the Department of Veteran Affairs; empowering federal law enforcement to prosecute animal abuse cases that cross state lines; and others, the spokesperson said. What The Experts Think Needs To Be Done The Trump administration's efforts to tackle the issue of animal testing appear to be a step in the right direction, according to experts who spoke with Newsweek. "I was pleasantly surprised and quite frankly a bit shocked to read the simultaneous announcements by the NIH and the FDA regarding a new emphasis on the use of alternatives to animals," Jeffrey Morgan, a professor of pathology and laboratory medicine at Brown University in Rhode Island, told Newsweek. Morgan, who is also the director of the Center for Alternatives to Animals in Testing at Brown University, said that both agencies are moving together in the same direction on the issue "sends a unified and very powerful message to the research and biotech communities." He added that the announcements showed "a major acknowledgement of the limitations of the use of animals in research and testing." "What is especially exciting is that the NIH announcement will encourage the entry of new investigators into the field, further accelerating innovation in alternatives with exciting impacts for both discovery and applied research across all diseases," he said. He added that the FDA announcement and its emphasis on a new regulatory science that embraces data from alternatives was "equally exciting." "The demands of this new regulatory science will likewise accelerate innovation because it will establish the much-needed regulatory framework for the rigorous evaluation of data from alternatives," he said. While the administration's initiatives to shift research away from animal testing is heading in the right direction, its policies are "overdue," Dr. Thomas Hartung, a professor in the department of environmental health and engineering at Johns Hopkins Bloomberg School of Public Health, Maryland, told Newsweek. "The animal tests for safety were introduced more than 50 years ago. There is no other area of science where we do not adapt to scientific progress," he said. Hartung added that animal "testing takes too long and is too expensive to really provide the safety consumers want." He said that running animal tests for new chemicals can cost millions and take years in some cases. "Nobody can wait that long, even if they can afford the testing costs," he said. Hartung also believes the shifts in the industry to reduce animal testing have been "coming for a while," as over the last two decades, America's opposition to animal use in medical research has been increasing. "The alignment of FDA and NIH really makes the difference now, which I think is evidence of a strong relationship of their leaderships," he said. Yet in order to make a real difference, Hartung said clear deadlines are key to show that "this is not just lip service." He also said that he thought "the transformative nature of artificial intelligence in this field is not fully acknowledged." "We also need an objective framework for change to better science, such as the evidence-based toxicology approach," he said.
Forbes
15 hours ago
- Forbes
How A Brain Bleed Decades Ago May Have Affected The Former President
TOPSHOT - US President Joe Biden looks on as he participates in the first presidential debate of the ... More 2024 elections with former US President and Republican presidential candidate Donald Trump at CNN's studios in Atlanta, Georgia, on June 27, 2024. (Photo by ANDREW CABALLERO-REYNOLDS / AFP) (Photo by ANDREW CABALLERO-REYNOLDS/AFP via Getty Images) AFP via Getty Images Over the past month or so, the media on both sides of the aisle have been filled with reports of concern about President Biden's cognitive decline while in office. This supports the observations of millions of Americans who watched the presidential debate last year. Several tell-all books have also been published pointing out episodes of decreased mental acuity—especially during the last two years of his administration. Several political leaders have been quoted as to the president's declining mental condition the last two years of his term. Many have volunteered episodes of forgetting names of key administration officials. Reports have also stated that the president may have forgotten several executive orders dealing with the environment that he had signed weeks earlier. The key event that may explain much of the cognitive issues being may have been a life- threatening event that occurred in the 1980's, when, then-senator Biden, had emergent brain surgery on a leaking brain aneurysm in February, 1988 repaired by Dr. Eugene George and Dr. Neal Kassell. The leaking brain aneurysm led to a subarachnoid hemorrhage, or bleeding in the space between your brain and a thin membrane that covers and protects it. A CT brain scan reveals a subarachnoid hemorrhage with clear signs of bleeding. getty In May of 1988, President Biden returned to the operating room to have a second smaller aneurysm managed by the same surgical team. Both were 'open procedures' where a clip was placed to manage the aneurysm. However, in the modern era of neurosurgery, brain aneurysms are preferentially managed (when possible) with less invasive procedures commonly referred to as endovascular procedures where coils are placed to prevent blood flow into an aneurysm by threading a thin catheter through an artery in the wrist or groin without the need to open the skull and dissect and potentially compromise brain tissue. There are currently no long-term studies on cognitive dysfunction related to traditional 'open procedures' compared to minimally invasive approaches known such as endovascular procedures. Endovascular coiling of aneurysm. Aneurysm treatment. Endovascular therapy. Vector poster getty Known complications related to leaking aneurysms (weakened or 'ballooning of blood vessels) also include spasm of small blood vessels in the brain. Such spasm of small blood vessels in the brain can also result in cognitive issues related to repairing and stabilizing such blood vessel abnormalities, whether by traditional opening of the skull (craniotomy) or even novel endovascular neurosurgical approaches. However, the risk of complications is generally known to be higher after a traditional or 'open-type' procedure which involves opening the skull in an invasive manner. What's clear is that the President of the United States is also the most observed individual on the planet and that changes in mental sharpness can be observed and reported by thousands of outlets in comparison to a similar patient who might be enjoying retirement. Cognitive dysfunction is a common complication of a brain bleed (such as a subarachnoid hemorrhage), which occurs when an aneurysm leaks or ruptures. This affects most people to some degree. Cognitive dysfunction can take a number of forms, such as problems with retrieval of memories prior to—but also after the bleeding occurrence. Equally concerning are issues remembering new information or facts. Brain damage associated with leaking or ruptured aneurysms may, in some cases, increase your risk of developing dementia. Research has also implicated surgery and the type of anesthesia utilized. Many studies have reported an association between multiple general anesthetics and dementia; this association remains controversial . Contemporary reports from the late 1980's do report some changes in then-Senator Biden. Alzheimer's disease is the most common dementia , followed by vascular dementia. Vascular and Alzheimer's dementia lead to impairment in number of executive functions including word-finding difficulties, deficits in reading comprehension, confusion and impaired focus and attention. The end result are alterations in brain protein structures, the result of the abnormal processing and organization of normal proteins in the brain. Vascular dementia is primarily caused by cerebrovascular disease due to atherosclerosis leading to irregular or abnormal blood flow to critical brain structures. There is also a large amount of research supporting the risks of developing dementia and Alzheimer's disease from traumatic brain injuries (TBIs) from playing football, soccer, lacrosse, wrestling, boxing and other contact sports. According to the Alzheimer's Association, research has provided a link between moderate to severe TBIs and a greater risk of developing some form of dementia years later. The symptoms of vascular dementia depend on the location and amount of brain tissue involved. They may appear suddenly after the acute event or slowly manifest over time. Symptoms of Dementia: Increased trouble doing normal daily activities because of problems with focus, communication or inability to follow directions. Memory problems: short-or long-term memory can be affected. Confusion which can get worse at night (so called sundowning syndrome) Personality changes. Mood changes such as depression or irritability. Stride changes when walking too fast of shuffling steps. Problems with movement, balance or both. Diagnosing dementia or Alzheimer's in any patient begins with evaluation by a skilled neurologist, along with specific blood biomarkers, specialized MRI scans, along with cognitive testing known as the The Montreal Cognitive Assessment (MoCA). Alzheimer's Disease is characterized by the presence of beta-amyloid , an abnormal substance which form sticky plaques on the brain which may result in death of brain cells. Testing for the presence of beta-amyloid plaques in the brain via specific blood biomarkers and MRI scans is critical in determining the extent of functional impairment. Individuals reviewing the last few years of President Biden's term might reflect on some of the events detailed in personal accounts made public in Jake Tapper's new book, Original Sin , that may serve as insight to stratify risk of cognitive impairment in older persons with previous neurologic events, even if they occurred many decades in the past. Dr. Peter J. Papakadakos , Professor of Anesthesiology and Director of Critical Care at University of Rochester Medical Center, contributed to this article.
Newsweek
17 hours ago
- Newsweek
Transgender Veterans Barred From Fertility Treatment Under New Rules
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. Transgender veterans eligible for Department of Veteran Affairs (VA) health benefits will no longer receive financial coverage for egg- and sperm-freezing fertility treatments, new guidance shows. According to a leaked email from a person at the VA's Women Veterans Health Care department, transgender veterans preparing for gender dysphoria treatment and seeking cryopreservation—the process in which eggs or sperm (gametes) are frozen and stored to be thawed for later use—will no longer see the costs of this process covered by the department. Treatment for gender dysphoria or gender identity disorder can affect an individual's ovaries or testes and thus fertility. Individuals sometimes freeze their eggs to mitigate against this prior to treatment. The email indicates a shift from previous policy. As it stands, everyone eligible for VA health care benefits (i.e. those who previously served in the military, navy or air service) can access these fertility preservation treatments, including transgender veterans, according to a Women Veterans Health Care document, published in October 2023. There are more than 134,000 transgender veterans in the U.S., according to the Williams Institute, a research center at UCLA School of Law that focuses on sexual orientation and gender identity. Newsweek contacted the VA by email to comment. A laboratory assistant shows a sperm sample in a cryopreservation container at minus-170 degrees Celsius at the Centre for Reproductive Medicine in Muenster, Germany, on February 6, 2013. A laboratory assistant shows a sperm sample in a cryopreservation container at minus-170 degrees Celsius at the Centre for Reproductive Medicine in Muenster, Germany, on February 6, 2013. Photo by: Friso Gentsch/picture-alliance/dpa/AP Images Since taking office for the second time, President Donald Trump has made a plethora of actions regarding transgender people, including signing an executive order stating that there are only two unchangeable sexes and another attempting to ban transgender women from competing in women's sports. He also signed an order aimed at restricting access to puberty blockers and other gender care for people under age 19. Some of the actions have sparked ongoing legal challenges. On February 18, he also signed an executive order expanding access to in vitro fertilization (IVF) and making it more affordable for patients. While IVF does not always require cryopreservation, it is often used to store excess embryos or to enable people to delay embryo transfer until a time of their choosing. The White House directed Newsweek to the VA after a request for comment. In the VA specifically, in March it was announced that the department was phasing out treatment for gender dysphoria in response to Trump's executive order recognizing two sexes. The VA said trans veterans would still continue to receive VA health care. The VA email, viewed by Newsweek said: "On yesterday's (6/16/2025) National Fertility Interdisciplinary Teams Office Hours call, it was announced that VA will no longer pay for cryopreservation of gametes for a medical indication if it involves transgender veterans seeking cryopreservation in preparation for treatment of Gender Dysphoria or Gender Identity Disorder. This will reportedly affect new authorizations and will not disrupt cryopreservation that has already been initiated." It added that according to another senior official in the Veterans Health Administration "the change is reportedly already in effect and an official announcement will be forthcoming" and advised the department to "hold on authorizing any new cryopreservation for medical indications related to gender dysphoria/gender identity disorder" while waiting for further guidance. "We want to avoid a situation where veterans could be told they are approved for cryo, only to find out after the fact that VA cannot pay for care they received," the email read. Newsweek chose not to name the person who sent the email as well as the senior official named in the correspondence to protect their privacy. According to the October 2023 Women Veterans Health Care document, fertility preservation of eggs and sperm, but not embryos, is covered by the VA for medical reasons. "If your VA health care provider determines there is a medical indication, VA can cover the cost of retrieving and freezing your eggs or sperm to preserve your fertility preservation," it said. It listed examples of medical indications that would be covered, including "veterans who are undergoing gender-affirming care that can affect their ovaries or testes." Roz Keith, the founder and executive director of the Michigan-based transgender charity Stand With Trans, said the policy was "discrimination." "Clearly, the rights of the trans community are the target of attack," she told Newsweek. "It doesn't matter whether someone is an adult, a minor, a veteran, a professional, or other, if one is trans identified, they are seeing rights being taken away one by one. It is deplorable. If one class of people can receive treatment paid for with their benefits, then other classes of people should receive the same. This is why we have the equal protection clause in our Constitution. "No one should be excluded from a particular treatment because they are transgender. This is the very definition of discrimination."
